Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Dealnews2025-11-08T12:38:25+00:00November 8th, 2025|The New York Times|
What Trump’s New Drug Pricing Deal Means for People With Obesitynews2025-11-06T21:53:59+00:00November 6th, 2025|The New York Times|
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugsnews2025-10-05T19:47:27+00:00October 5th, 2025|The New York Times|
Un fármaco común para perder peso puede tratar una enfermedad hepática grave, según la FDAnews2025-08-19T07:02:57+00:00August 19th, 2025|The New York Times|
Wegovy Gets F.D.A. Approval for MASHnews2025-08-18T17:21:18+00:00August 18th, 2025|The New York Times|
Pill Causes Major Weight Loss in Eli Lilly Trial’s Resultsnews2025-08-07T11:37:14+00:00August 7th, 2025|The New York Times|
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drugnews2025-05-12T00:08:25+00:00May 12th, 2025|The New York Times|
What to Know About Eli Lilly’s Daily Pill for Weight Lossnews2025-04-17T21:24:51+00:00April 17th, 2025|The New York Times|
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycatsnews2025-04-16T14:43:02+00:00April 16th, 2025|The New York Times|
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugsnews2025-04-04T23:42:16+00:00April 4th, 2025|The New York Times|
